3-42091521-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000327628.10(TRAK1):c.52G>A(p.Gly18Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000179 in 1,613,490 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
ENST00000327628.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRAK1 | NM_001042646.3 | c.52G>A | p.Gly18Arg | missense_variant | 1/16 | ENST00000327628.10 | NP_001036111.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRAK1 | ENST00000327628.10 | c.52G>A | p.Gly18Arg | missense_variant | 1/16 | 1 | NM_001042646.3 | ENSP00000328998 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000101 AC: 25AN: 248360Hom.: 0 AF XY: 0.000119 AC XY: 16AN XY: 134818
GnomAD4 exome AF: 0.000189 AC: 276AN: 1461164Hom.: 0 Cov.: 30 AF XY: 0.000184 AC XY: 134AN XY: 726946
GnomAD4 genome AF: 0.0000853 AC: 13AN: 152326Hom.: 0 Cov.: 32 AF XY: 0.0000940 AC XY: 7AN XY: 74496
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 07, 2022 | The c.52G>A (p.G18R) alteration is located in exon 1 (coding exon 1) of the TRAK1 gene. This alteration results from a G to A substitution at nucleotide position 52, causing the glycine (G) at amino acid position 18 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 05, 2024 | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 18 of the TRAK1 protein (p.Gly18Arg). This variant is present in population databases (rs200776452, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with TRAK1-related conditions. ClinVar contains an entry for this variant (Variation ID: 2392037). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The arginine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at